A nanoparticle-based deep brain stimulation system has successfully reversed Parkinson’s disease symptoms in mice by boosting dopamine levels and clearing out harmful fibrils.
Current DBS treatments aim to amplify dopamine signaling, but do not stop disease progression by restoring degenerated neurons.
Researchers developed a photothermal, wireless DBS system using TRPV1 activation and β-syn peptides to clear α-syn fibrils in the brain.
The DBS nanoparticles anchor to dopamine neurons, convert NIR irradiation into heat, activate TRPV1 receptors, and trigger autophagy.
In vitro tests showed the nanoparticles reduced neuron death induced by α-syn preformed fibrils.
In vivo studies in mice with Parkinson's disease demonstrated improved motor abilities and restored dopamine neurons after DBS treatment.
Motor tests showed treated mice outperformed untreated ones and had near comparable performance to healthy mice.
The nanoparticles remained stable in the brain with no considerable toxicity observed after treatment.
Future research aims to further explore gold clusters' neuroprotective properties for potential multifunctional therapeutic strategies.
The study was reported in Science Advances and offers promising insights into innovative treatments for Parkinson’s disease.